Medivation Announces Participation at Upcoming Investor Conference

Medivation Announces Participation at Upcoming Investor Conference 
SAN FRANCISCO, CA -- (Marketwired) -- 08/27/13 --  Medivation, Inc.
(NASDAQ: MDVN) today announced that it will present at the following
conference: 


 
--  David Hung, M.D., president and chief executive officer, will present
    at the Morgan Stanley Global Healthcare Conference on September 10 at
    1:30pm ET at the Grand Hyatt in New York, NY.

  
Individuals may access the live audio webcast by visiting:
http://investors.medivation.com/events.cfm. A replay of the webcast
will be available on the Company's website for 30 days following the
live event. 
About Medivation
 Medivation, Inc. is a biopharmaceutical company
focused on the rapid development of novel therapies to treat serious
diseases for which there are limited treatment options. Medivation
aims to transform the treatment of these diseases and offer hope to
critically ill patients and their families. For more information,
please visit us at www.medivation.com. 
Contacts:
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101 
Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900